scholarly journals All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

Hepatology ◽  
2015 ◽  
Vol 61 (4) ◽  
pp. 1127-1135 ◽  
Author(s):  
David R. Nelson ◽  
James N. Cooper ◽  
Jacob P. Lalezari ◽  
Eric Lawitz ◽  
Paul J. Pockros ◽  
...  
Hepatology ◽  
2016 ◽  
Vol 63 (5) ◽  
pp. 1430-1441 ◽  
Author(s):  
Vincent Leroy ◽  
Peter Angus ◽  
Jean‐Pierre Bronowicki ◽  
Gregory J. Dore ◽  
Christophe Hezode ◽  
...  

2019 ◽  
Vol 26 (4) ◽  
pp. 459-465 ◽  
Author(s):  
Sang Soo Lee ◽  
Cha Young Kim ◽  
Bo Ra Kim ◽  
Ra Ri Cha ◽  
Wan Soo Kim ◽  
...  

2010 ◽  
Vol 82 (10) ◽  
pp. 1647-1654 ◽  
Author(s):  
Christine Larsen ◽  
Vanina Bousquet ◽  
Elisabeth Delarocque-Astagneau ◽  
Corinne Pioche ◽  
Françoise Roudot-Thoraval

2013 ◽  
Vol 13 (8) ◽  
Author(s):  
Faraz Salehi Moghadam ◽  
Seyed Reza Mohebbi ◽  
Seyed Masoud Hosseini ◽  
Behzad Damavand ◽  
Mohammad Reza Zali

Sign in / Sign up

Export Citation Format

Share Document